EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

An update on methods for detection of prognostic and predictive biomarkers in melanoma

Oluwaseyi Adeuyan, Emily R Gordon, Divya Kenchappa, Yadriel Bracero, Ajay Singh, Gerardo Espinoza, Larisa J Geskin, Yvonne M Saenger

Frontiers in Cell and Developmental Biology · 13.10.2023 · 11

DOI: 10.3389/fcell.2023.1290696 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 13.10.2023. Verfasst von Oluwaseyi Adeuyan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The approval of immunotherapy for stage II-IV melanoma has underscored the need for improved immune-based predictive and prognostic biomarkers. For resectable stage II-III patients, adjuvant immunotherapy has proven clinical benefit, yet many patients experience significant adverse events and may not require therapy. In the metastatic setting, single agent immunotherapy cures many patients but, in some cases, more intensive combination therapies against specific molecular targets are required. Therefore, the establishment of additional biomarkers to determine a patient’s disease outcome (i.e., prognostic) or response to treatment (i.e., predictive) is of utmost importance. Multiple methods ranging from gene expression profiling of bulk tissue, to spatial transcriptomics of single cells and artificial intelligence-based image analysis have been utilized to better characterize the immune microenvironment in melanoma to provide novel predictive and prognostic biomarkers. In this review, we will highlight the different techniques currently under investigation for the detection of prognostic and predictive immune biomarkers in melanoma.

Schlagwörter

Stichwörter der Autor:innen

checkpoint inhibitionimmunotherapymelanomapredictive biomarkerprognostic biomarker

Autor:innen und Institutionen

  • Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States.
  • Albert Einstein College of Medicine, Bronx, NY, United States.
  • Department of Dermatology, Columbia University Irving Medical Center, New York, NY, United States.

Förderung

  • NCI NIH HHS

Zitieren

APA

Adeuyan, O., Gordon, E. R., Kenchappa, D., Bracero, Y., Singh, A., Espinoza, G., Geskin, L. J., & Saenger, Y. M. (2023). An update on methods for detection of prognostic and predictive biomarkers in melanoma. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1290696

Vancouver

Adeuyan O, Gordon ER, Kenchappa D, Bracero Y, Singh A, Espinoza G, et al. An update on methods for detection of prognostic and predictive biomarkers in melanoma. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1290696

BibTeX
@article{Adeuyan2023,
  author = {Adeuyan, Oluwaseyi and Gordon, Emily R and Kenchappa, Divya and Bracero, Yadriel and Singh, Ajay and Espinoza, Gerardo and Geskin, Larisa J and Saenger, Yvonne M},
  title = {An update on methods for detection of prognostic and predictive biomarkers in melanoma},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2023},
  volume = {11},
  doi = {10.3389/fcell.2023.1290696}
}
Kostenlos starten →